Greenwich LifeSciences (GLSI) Analyst & Key Data

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

2

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$15.45

Median Target+223.62%

$50.00

Potential upside vs current price

DCF Value-99.13%

$0.13

Potential downside vs current price

Current Stock Price

$15.45

Median Target+223.62%

$50.00

Potential upside vs current price

DCF Value-99.13%

$0.13

Potential downside vs current price

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

2

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$15.45

Median Target+223.62%

$50.00

Potential upside vs current price

DCF Value-99.13%

$0.13

Potential downside vs current price

Current Stock Price

$15.45

Median Target+223.62%

$50.00

Potential upside vs current price

DCF Value-99.13%

$0.13

Potential downside vs current price

Greenwich LifeSciences, Inc.